Quantitative Chemical Proteomics Identifies Novel Targets of the Anti-cancer Multi-kinase Inhibitor E-3810
出版年份 2014 全文链接
标题
Quantitative Chemical Proteomics Identifies Novel Targets of the Anti-cancer Multi-kinase Inhibitor E-3810
作者
关键词
-
出版物
MOLECULAR & CELLULAR PROTEOMICS
Volume 13, Issue 6, Pages 1495-1509
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2014-04-03
DOI
10.1074/mcp.m113.034173
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis
- (2013) Kun Zhang et al. NATURE CELL BIOLOGY
- Mass Spectrometry-Based Proteomics in Preclinical Drug Discovery
- (2012) Markus Schirle et al. CHEMISTRY & BIOLOGY
- The Tyrosine Kinase Inhibitor E-3810 Combined with Paclitaxel Inhibits the Growth of Advanced-Stage Triple-Negative Breast Cancer Xenografts
- (2012) E. Bello et al. MOLECULAR CANCER THERAPEUTICS
- E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR that Exerts Antitumor Activity in Multiple Preclinical Models
- (2011) Ezia Bello et al. CANCER RESEARCH
- Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
- (2011) Jürgen Cox et al. JOURNAL OF PROTEOME RESEARCH
- GProX, a User-Friendly Platform for Bioinformatics Analysis and Visualization of Quantitative Proteomics Data
- (2011) Kristoffer T. G. Rigbolt et al. MOLECULAR & CELLULAR PROTEOMICS
- Global quantification of mammalian gene expression control
- (2011) Björn Schwanhäusser et al. NATURE
- Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
- (2011) Marcus Bantscheff et al. NATURE BIOTECHNOLOGY
- Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
- (2011) Peter S. Hammerman et al. Cancer Discovery
- Extracting gene function from protein–protein interactions using Quantitative BAC InteraCtomics (QUBIC)
- (2010) Nina C. Hubner et al. METHODS
- Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases
- (2009) F. Qian et al. CANCER RESEARCH
- Target profiling of small molecules by chemical proteomics
- (2009) Uwe Rix et al. Nature Chemical Biology
- Proteomics strategy for quantitative protein interaction profiling in cell extracts
- (2009) Kirti Sharma et al. NATURE METHODS
- Identifying the proteins to which small-molecule probes and drugs bind in cells
- (2009) S.-E. Ong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The structure of the leukemia drug imatinib bound to human quinone reductase 2 (NQO2)
- (2009) Jonathan A Winger et al. BMC STRUCTURAL BIOLOGY
- Pleiotropic effects of selective CDK inhibitors on human normal and cancer cells
- (2008) Józefa Węsierska-Gądek et al. BIOCHEMICAL PHARMACOLOGY
- Therapeutic Protein Kinase Inhibitors
- (2008) S. K. Grant CELLULAR AND MOLECULAR LIFE SCIENCES
- Novel 2,3-Dihydro-1,4-Benzoxazines as Potent and Orally Bioavailable Inhibitors of Tumor-Driven Angiogenesis∥
- (2008) Daniel S. La et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery and Optimization of Triazolopyridazines as Potent and Selective Inhibitors of the c-Met Kinase†
- (2008) Brian K. Albrecht et al. JOURNAL OF MEDICINAL CHEMISTRY
- Naphthamides as Novel and Potent Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: Design, Synthesis, and Evaluation¶
- (2008) Jean-Christophe Harmange et al. JOURNAL OF MEDICINAL CHEMISTRY
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
- (2008) Jürgen Cox et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More